You’ve tried the things that were supposed to help. Talk therapy. One antidepressant, then another. Maybe EMDR or exposure work. And still, the hypervigilance doesn’t fully lift. Sleep stays broken. The past keeps showing up in the present, uninvited.
If that’s where you are, this guide is for you. It explains what IV ketamine therapy for PTSD involves, what the research shows for people whose symptoms haven’t responded to standard care, and how the treatment works at a Manhattan clinic built around safety, preparation, and integration. Nothing here is a promise. It’s an honest look at an option worth understanding.
What “nothing has worked” usually means
Post-traumatic stress disorder (PTSD) is a mental health condition that can develop after a frightening or life-threatening event. It’s more common than many people realize. According to the National Institute of Mental Health, an estimated 6.8% of U.S. adults experience PTSD at some point in their lives, and 3.6% had it in the past year. The condition affects more women (5.2% in the past year) than men (1.8%).
Standard first-line care usually means trauma-focused psychotherapy, an SSRI or SNRI antidepressant, or both. These help many people. They don’t help everyone. When symptoms persist after adequate trials of these approaches, clinicians sometimes describe the situation as treatment-resistant. That’s a clinical label about how the illness has responded to specific treatments. It isn’t a verdict about you, and it isn’t the end of the road.
For people in that position, ketamine has drawn attention as a different kind of option. It works through a different mechanism than traditional antidepressants, and it can act quickly.
What IV ketamine therapy is
IV ketamine is a low dose of ketamine delivered slowly into a vein (intravenously) under medical supervision. Ketamine is a medication that has been used safely in hospitals as an anesthetic for decades. At the much lower doses used for mental health, it works on the brain differently than SSRIs do.
Rather than adjusting serotonin over weeks, ketamine acts on the glutamate system and blocks a receptor called NMDA (N-methyl-D-aspartate). This appears to support neuroplasticity, the brain’s ability to form new connections and adapt. For someone with PTSD, that window of flexibility may create an opening to process difficult material and loosen patterns that have felt fixed.
A few terms worth defining, since you’ll hear them:
- Dissociation is a temporary shift in how you experience your body, thoughts, and surroundings. During a session, some people feel a sense of distance from their usual sense of self. This is expected and monitored, and it fades as the medicine clears.
- Integration is the work of making sense of what came up during a session and carrying it into daily life. It typically happens in conversations with a therapist or integration coach afterward.
- Esketamine (Spravato) is a nasal-spray form of ketamine approved by the FDA for treatment-resistant depression and administered in certified settings. It’s a related but separate option from IV ketamine.
For a closer look at how a session actually feels, our guide on what to expect during a ketamine infusion walks through it step by step.
What the research shows for treatment-resistant PTSD
Here’s the part that matters most if you’ve run out of things to try: the evidence for ketamine in PTSD is genuinely promising, and it appears strongest when the medicine is delivered in a supportive, therapy-rich setting rather than as a standalone injection.
A 2025 study published in the Journal of Psychopharmacology, “Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm” by Henry A. MacConnel, Mitch Earleywine, and Steven Radowitz,1 looked at 117 people with treatment-resistant PTSD who received IV ketamine alongside preparation, integration, and sensory support like eye masks and music. On average, symptom scores on a standard PTSD checklist fell from 52.54 to 28.78. Among the group, about 75% showed clinically meaningful improvement and roughly 62% reached remission, meaning their symptoms dropped below the threshold for a PTSD diagnosis. Treatment was well tolerated, with no serious adverse events reported.
Two things are worth holding in mind. First, this was a real-world chart review, not a randomized controlled trial, and the authors themselves call for controlled studies to confirm the findings. Second, the researchers point to the setting as part of the story. Earlier ketamine-for-PTSD studies have produced mixed results, and one likely reason is that the environment and the therapeutic support around the medicine vary widely. When those elements are strong, outcomes appear to improve.
That distinction shapes how we think about care.
Why setting and support change the outcome
Ketamine is a catalyst, not a cure. The medicine can open a window; what you do inside that window is where durable change tends to come from. This is why preparation and integration aren’t extras at Nushama. They’re the treatment.
Before any medicine is given, you meet with a licensed clinician or integration coach to talk through your history, your current symptoms, and what you hope to work on. This builds trust and sets clear intentions. It’s also where you learn grounding techniques you can lean on if hard emotions surface during a session.
The session itself takes place in a private, calm space rather than a clinical exam room. You recline in a zero-gravity chair, put on an eye mask and headphones with curated music, and a physician monitors you throughout. Because the dose is delivered by IV, it can be adjusted in real time, which gives the medical team precise control over your experience. If anything needs to stop, it can, immediately.
Afterward comes integration: structured conversations that help you translate insights into changes you can actually live. You can read more about why this phase matters in our piece on the importance of ketamine integration.
Why we use IV over other forms
There are several ways to take ketamine, including nasal sprays and lozenges, and at-home options have become more common. For PTSD care, we default to IV for a specific reason: control.
An intravenous infusion lets the physician titrate the dose gradually and respond to how you’re doing minute by minute. At-home and intranasal formats can be less predictable in how much medicine reaches the bloodstream and how a person responds, and they lack in-room medical monitoring. That doesn’t make other formats wrong for every situation. It means that for a condition as sensitive as trauma, we favor the approach that offers the most precision and the most oversight. Our comparison of IV versus intramuscular ketamine goes deeper on the trade-offs.
Is IV ketamine right for you? Safety and screening
Ketamine isn’t appropriate for everyone, and a careful screening is where care begins. Before treatment, you’ll complete a medical and psychiatric assessment. This helps the team understand your full picture and check for conditions that could make ketamine unsafe.
Some factors call for caution or may rule out treatment, including uncontrolled high blood pressure, certain heart or vascular conditions, active psychosis or a history of certain psychotic disorders, pregnancy, and a history of ketamine misuse. This isn’t a complete list, and only a clinician who knows your situation can advise you. The point of screening is simple: to make sure this is a safe and reasonable option for you specifically.
Throughout treatment, you’re monitored by medical staff, your dose is individualized, and you have integration support around each session. This structure exists so you can focus on healing while the clinical details are handled with care.
If you’re weighing this against other approaches, our overview of alternative PTSD treatments can help you compare options with clear eyes.
Finding ketamine therapy for PTSD in Manhattan
If you’re searching for ketamine therapy for PTSD in Manhattan because the usual paths haven’t led anywhere, a few questions can help you choose a clinic well:
- Does the clinic screen thoroughly before treatment? A proper medical and psychiatric intake should come first, always.
- Is a physician present and monitoring during infusions? Continuous medical oversight matters, especially for trauma.
- Is preparation and integration part of the program, or is it medicine only? The research suggests the support around the medicine shapes the outcome.
- Does the setting feel safe and calm? For trauma work, environment isn’t a luxury. It’s part of what makes the work possible.
Nushama was built around these principles: medical rigor, a serene setting, and a full arc of preparation, journey, and integration. You can learn more about how our approach differs from medication-only clinics.
Frequently asked questions
How quickly might ketamine help with PTSD symptoms? Some people notice shifts within the first days to weeks, which is faster than the six to twelve weeks typical of SSRIs. Responses vary, and durable change usually depends on completing a series of sessions with integration support. Your care team will map out a plan based on how you respond.
Is IV ketamine addictive at these doses? The doses used for supervised PTSD treatment are low and given in a controlled clinical setting, which is very different from recreational misuse. Screening includes reviewing any history of substance use, and treatment is monitored throughout. Share any concerns with your clinician during intake.
How many sessions will I need? There’s no single answer. Many protocols involve a series of infusions over several weeks, followed by a plan for maintenance if it’s helpful. Your clinician will individualize this based on your symptoms and your response.
Will I be unconscious during the infusion? No. IV ketamine for mental health uses low doses. You remain awake and are monitored the whole time. Some people experience dissociation, a temporary sense of distance from their usual perception, which fades as the medicine clears.
Can I keep taking my other medications? Often yes, but this depends on your specific regimen. Ketamine has minimal interaction with many psychiatric medications, though your prescriber will review everything during screening to be sure.
Is ketamine therapy covered by insurance? Coverage varies. IV ketamine for PTSD is often not covered, while esketamine (Spravato) may be in some cases. Our care team can walk you through options during a consultation.
A grounded next step
Living with PTSD when the standard treatments haven’t worked is exhausting, and it’s reasonable to feel wary of one more thing that might not help. IV ketamine isn’t a miracle, and no honest clinic will tell you it is. What the evidence suggests is that, delivered with medical oversight and real therapeutic support, it may offer meaningful relief for many people who felt out of options.
If you’d like to understand whether it fits your situation, the next step is a conversation, not a commitment. Speak with our care team to ask your questions and learn what a personalized plan might look like.
1 MacConnel HA, Earleywine M, Radowitz S. “Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm.” Journal of Psychopharmacology, 2025. PubMed